Seven ANZ startups that raised $93.1 million this week
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.
Venture capital fund · 4 deals
Adelaide, SA
Every published round South Australian Venture Capital Fund took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| FerronovaPrecision cancer treatment technology | Series A | 17 Dec 2025 | $6m | Lead | movefm.com.au, ferronova.com.au, Artesian VC portfolio, Artesian VC portfolio | |
| Ferronova | Series A | 17 Dec 2025 | $6m | Lead | Wholesale Investor (29 Jan 2026), Wholesale Investor (16 Jan 2026), Startup Daily (19 Dec 2025), SmartCompany, Biotech Dispatch, Uniseed, Startup Daily (17 Dec 2025), Business News Australia, biospectrumasia.com, South Australian Venture Capital Fund portfolio | |
| Fivecast | Series A | 11 Apr 2023 | $29.8m | Participant | Forbes Australia, SmartCompany (14 Apr 2023), Startup Daily, SmartCompany (11 Apr 2023), Main Sequence Ventures portfolio, South Australian Venture Capital Fund portfolio | |
| BiomeBank | Unnamed stage | 9 Dec 2022 | $10.7m | Participant | Techboard, SmartCompany, Forbes Australia |
Companies South Australian Venture Capital Fund has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| BiomeBank | 9 Dec 2022 | 1 | 0 | |
| Fivecast | Adelaide-based Security AI Software startup | 11 Apr 2023, Series A | 1 | 0 |
| Ferronova | advance image-guided cancer surgery | 17 Dec 2025, Series A | 1 | 1 |
| FerronovaPrecision cancer treatment technology | 17 Dec 2025, Series A | 1 | 1 |
Companies South Australian Venture Capital Fund's own portfolio page lists that no published round yet places it in. The page is the source; the round is being looked for.
| Company | Site |
|---|---|
| Fleet | - |
| Kid Sense | - |
| Kindship | - |
| Lumary | - |
| Myriota | - |
| Pearler.AI | - |
| Seonix Bio | - |
| Val.AI | - |
Fund closes reported for South Australian Venture Capital Fund, as distinct from the investments it has made.
Companies South Australian Venture Capital Fund has backed that another company then bought. An exit for the holding, not a deal South Australian Venture Capital Fund did.
Stories naming South Australian Venture Capital Fund. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.
Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily
Adelaide AI firm Fivecast has raised a $30 million Series A led by Ten Eleven, with Main Sequence and the South Australian Venture Capital Fund joining, to expand into overseas markets and grow headcount.
Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.
Also SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.
Weekly roundup covering 14 startup raises totalling over $260 million, headlined by Synchron's $110 million round, plus Roller's shareholder liquidity payout, Partly's record New Zealand Series A, and several government grants.
Also Startup Daily·Startup Daily·Techboard·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup News (WA)·Startup News (WA)
Biotech firm BiomeBank raised $10.65 million from Ellerston Capital, the South Australian Venture Capital Fund and The Hospital Research Foundation to expand manufacturing and advance its microbiome therapies.
Also SmartCompany·Techboard